tiprankstipranks
Trending News
More News >
OnKure Therapeutics (OKUR)
NASDAQ:OKUR
US Market
Advertisement

OnKure Therapeutics (OKUR) Financial Statements

Compare
299 Followers

OnKure Therapeutics Financial Overview

OnKure Therapeutics's market cap is currently $31.48M. The company's EPS TTM is $-1.19; its P/E ratio is ―; OnKure Therapeutics is scheduled to report earnings on May 6, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00
Operating Income$ -54.39M$ -36.93M$ -29.77M
EBITDA$ -51.71M$ -34.75M$ -29.38M
Net Income$ -52.67M$ -35.31M$ -29.51M
Balance Sheet
Cash & Short-Term Investments$ 110.76M$ 29.88M$ 11.54M
Total Assets$ 114.91M$ 35.73M$ 16.00M
Total Debt$ 1.08M$ 674.00K$ 637.00K
Net Debt$ -109.68M$ -29.20M$ -10.91M
Total Liabilities$ 11.08M$ 137.58M$ 70.42M
Stockholders' Equity$ 103.83M$ -101.84M$ -54.42M
Cash Flow
Free Cash Flow$ -51.17M$ -34.79M$ -28.09M
Operating Cash Flow$ -51.12M$ -34.55M$ -26.95M
Investing Cash Flow$ 15.87M$ -246.00K$ -1.13M
Financing Cash Flow$ 116.13M$ 53.13M$ 26.46M
Currency in USD

OnKure Therapeutics Earnings and Revenue History

OnKure Therapeutics Debt to Assets

OnKure Therapeutics Cash Flow

OnKure Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis